These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8375242)

  • 1. Glycemic actions of alanine and terbutaline in IDDM.
    Wiethop BV; Cryer PE
    Diabetes Care; 1993 Aug; 16(8):1124-30. PubMed ID: 8375242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alanine and terbutaline in treatment of hypoglycemia in IDDM.
    Wiethop BV; Cryer PE
    Diabetes Care; 1993 Aug; 16(8):1131-6. PubMed ID: 8375243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
    Berk MA; Clutter WE; Skor D; Shah SD; Gingerich RP; Parvin CA; Cryer PE
    J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM.
    Saleh TY; Cryer PE
    Diabetes Care; 1997 Aug; 20(8):1231-6. PubMed ID: 9250445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.
    Rattarasarn C; Dagogo-Jack S; Zachwieja JJ; Cryer PE
    Diabetes; 1994 Jun; 43(6):809-18. PubMed ID: 8194668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM.
    Caprio S; Tamborlane WV; Zych K; Gerow K; Sherwin RS
    Diabetes; 1993 Apr; 42(4):550-5. PubMed ID: 8454105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDM.
    Hirsch IB; Smith LJ; Havlin CE; Shah SD; Clutter WE; Cryer PE
    Diabetes Care; 1990 Feb; 13(2):133-42. PubMed ID: 2190769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin regulation of lipolysis in nondiabetic and IDDM subjects.
    Jensen MD; Caruso M; Heiling V; Miles JM
    Diabetes; 1989 Dec; 38(12):1595-601. PubMed ID: 2573554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
    Dagogo-Jack S; Rattarasarn C; Cryer PE
    Diabetes; 1994 Dec; 43(12):1426-34. PubMed ID: 7958494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans.
    Davis MR; Shamoon H
    Metabolism; 1992 Feb; 41(2):216-23. PubMed ID: 1736045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
    Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.
    Dagogo-Jack SE; Craft S; Cryer PE
    J Clin Invest; 1993 Mar; 91(3):819-28. PubMed ID: 8450063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
    Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
    J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM.
    Torlone E; Pampanelli S; Lalli C; Del Sindaco P; Di Vincenzo A; Rambotti AM; Modarelli F; Epifano L; Kassi G; Perriello G; Brunetti P; Bolli G
    Diabetes Care; 1996 Sep; 19(9):945-52. PubMed ID: 8875087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence against important catecholamine compensation for absent glucagon counterregulation.
    De Feo P; Perriello G; Torlone E; Fanelli C; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E203-12. PubMed ID: 1996624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients. Evidence for a critical role of free fatty acids.
    Avogaro A; Beltramello P; Gnudi L; Maran A; Valerio A; Miola M; Marin N; Crepaldi C; Confortin L; Costa F
    Diabetes; 1993 Nov; 42(11):1626-34. PubMed ID: 8405705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated glucose recovery from hypoglycemia in the elderly.
    Marker JC; Cryer PE; Clutter WE
    Diabetes; 1992 Jun; 41(6):671-8. PubMed ID: 1587394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
    Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD
    Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.